Xarelto and Optic nerve infarction - a phase IV clinical study of FDA data
Optic nerve infarction is reported only by a few people who take Xarelto.
The phase IV clinical study analyzes which people take Xarelto and have Optic nerve infarction. It is created by eHealthMe based on reports of 195,181 people who have side effects while taking Xarelto from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
195,181 people reported to have side effects when taking Xarelto.
Among them, 3 people (0.0%) have Optic nerve infarction.
What is Xarelto?
Xarelto has active ingredients of rivaroxaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 197,062 Xarelto users for its effectiveness, alternative drugs and more.
What is Optic nerve infarction?
Optic nerve infarction (optic nerve fibre damage) is found to be associated with 170 drugs and 91 conditions by eHealthMe.
Number of Xarelto and Optic nerve infarction reports submitted per year:
Time on Xarelto when people have Optic nerve infarction *:
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Optic nerve infarction when taking Xarelto *:
- female: 33.33 %
- male: 66.67 %
Age of people who have Optic nerve infarction when taking Xarelto *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 33.33 %
- 60+: 66.67 %
Common drugs people take besides Xarelto *:
- Protonix: 1 person, 33.33%
- Multaq: 1 person, 33.33%
- Lipitor: 1 person, 33.33%
- Bystolic: 1 person, 33.33%
- Benicar: 1 person, 33.33%
- Amlodipine: 1 person, 33.33%
Common side effects people have besides Optic nerve infarction *:
- Vision Blurred: 1 person, 33.33%
- Vascular Occlusion (sudden blockage of a blood vessel, usually with a clot): 1 person, 33.33%
- Papilloedema (optic disc swelling): 1 person, 33.33%
- Nosebleed (bleeding from nose): 1 person, 33.33%
- Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 1 person, 33.33%
- Coughing Up Blood: 1 person, 33.33%
- Blindness: 1 person, 33.33%
- Anaemia (lack of blood): 1 person, 33.33%
Common conditions people have *:
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 66.67%
* Approximation only. Some reports may have incomplete information.
Do you take Xarelto and have Optic nerve infarction?Check whether Optic nerve infarction is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Optic nerve infarction and when was it recovered:
Expand to all the drugs that have ingredients of rivaroxaban:
Alternative drugs to, pros and cons of Xarelto:
- Xarelto (197,062 reports)
Common Xarelto side effects:
- Nosebleed (bleeding from nose): 7,535 reports
- Death: 6,147 reports
- Breathing difficulty: 5,968 reports
- Fatigue (feeling of tiredness): 5,818 reports
Browse all side effects of Xarelto:a b c d e f g h i j k l m n o p q r s t u v w x y z
Optic nerve infarction treatments and more:
- Optic nerve infarction (154 reports)
COVID vaccines that are related to Optic nerve infarction:
- Optic nerve infarction in Moderna COVID Vaccine
- Optic nerve infarction in Pfizer BioNTech Covid Vaccine
- Optic nerve infarction in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Optic nerve infarction:
- Optic nerve infarction (170 drugs)
All the conditions that are associated with Optic nerve infarction:
- Optic nerve infarction (91 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on rivaroxaban (the active ingredients of Xarelto) and Xarelto (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Equetro vs. Neurontin - a second ago
- Tenormin vs. Carvedilol - 10 seconds ago
- Tamsulosin and Dexilant drug interaction - 10 seconds ago
- Tamsulosin and Q10 drug interaction - 19 seconds ago
- Zanaflex and Eyelid Twitch - 19 seconds ago
- Eliquis and Cardiac Flutter - 19 seconds ago
- Tamsulosin and Dilaudid drug interaction - 24 seconds ago
- Sam-E vs. Loraz - 31 seconds ago
- Victoza vs. Ionamin - 31 seconds ago
- Norpramin vs. Omega 3 - 36 seconds ago